Grant of options

Futura Medical PLC 22 March 2005 RNS Release 22 March 2005 Futura Medical grant of options Futura Medical plc (the 'Company'), the AIM-quoted pharmaceutical drug and medical device group that develops innovative products for the sexual healthcare market, announces that the Board of the Company has today granted options over ordinary shares of 0.2 pence each ('Ordinary Shares') to the following directors of the Company at an option exercise price of 76 pence per share (being the closing mid-market price yesterday): Director Number of Number of Ordinary Shares Options Granted over which options held following this notification James Barder 100,000 350,000 Anthony Clayden 100,000 775,000 David Davies 100,000 1,250,000 Bill Potter 50,000 425,000 No consideration was paid for the grant of these options. The period during which the options granted today are exercisable is from 1 April 2007 to 31 March 2009. For further information: Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 845 670 Media enquiries: Abchurch Peter Curtain Tel: +44 (0) 20 7398 7700 mailto: Peter.Curtain@abchurch-group.com www.abchurch-group.com www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange